2022-2027 Global and Regional Opioids Drug Industry Status and Prospects Professional Market Research Report Standard Version
Date: Jan-2022 | Id: MACRC-74092 | Geographical Scope: Global | Publisher: Mnemonics Research
The global Opioids Drug market was valued at 1054.41 Million USD in 2021 and will grow with a CAGR of 1.88% from 2021 to 2027, based on Mnemonics Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.The classification of Opioids Drug includes Oxycodone, Hydromorphone, Codeine, Fentanyl and Other, and the revenue proportion of Oxycodone in 2016 is about 33%, and the proportion is in decreasing trend from 2012 to 2016. Opioids Drug is widely used for Pain Relief, Anesthesia and Other. The most proportion of Opioids Drug is for Pain Relief, and the proportion in 2016 is about 66.5%. North America is the largest supplier of Opioids Drug, with a production market share nearly 71% in 2016. Europe is the second largest supplier of Opioids Drug Media, enjoying production market share nearly 16% in 2016. North America is the largest consumption place, with a consumption market share nearly 60.5 % in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 20%. Market competition is not intense. Purdue Pharma, J&J, Teva, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry. By Market Verdors: Teva Purdue Pharma Mallinckrodt Amneal Pharma Collegium J&J Endo Pfizer INSYS Mylan Hikma Egalet By Types: Oxycodone Hydromorphone Codeine Fentanyl By Applications: Pain Relief Anesthesia Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview 1.1 Definition 1.2 Assumptions 1.3 Research Scope 1.4 Market Analysis by Regions 1.4.1 North America Market States and Outlook (2022-2027) 1.4.2 East Asia Market States and Outlook (2022-2027) 1.4.3 Europe Market States and Outlook (2022-2027) 1.4.4 South Asia Market States and Outlook (2022-2027) 1.4.5 Southeast Asia Market States and Outlook (2022-2027) 1.4.6 Middle East Market States and Outlook (2022-2027) 1.4.7 Africa Market States and Outlook (2022-2027) 1.4.8 Oceania Market States and Outlook (2022-2027) 1.4.9 South America Market States and Outlook (2022-2027) 1.5 Global Opioids Drug Market Size Analysis from 2022 to 2027 1.5.1 Global Opioids Drug Market Size Analysis from 2022 to 2027 by Consumption Volume 1.5.2 Global Opioids Drug Market Size Analysis from 2022 to 2027 by Value 1.5.3 Global Opioids Drug Price Trends Analysis from 2022 to 2027 1.6 COVID-19 Outbreak: Opioids Drug Industry Impact Chapter 2 Global Opioids Drug Competition by Types, Applications, and Top Regions and Countries 2.1 Global Opioids Drug (Volume and Value) by Type 2.1.1 Global Opioids Drug Consumption and Market Share by Type (2016-2021) 2.1.2 Global Opioids Drug Revenue and Market Share by Type (2016-2021) 2.2 Global Opioids Drug (Volume and Value) by Application 2.2.1 Global Opioids Drug Consumption and Market Share by Application (2016-2021) 2.2.2 Global Opioids Drug Revenue and Market Share by Application (2016-2021) 2.3 Global Opioids Drug (Volume and Value) by Regions 2.3.1 Global Opioids Drug Consumption and Market Share by Regions (2016-2021) 2.3.2 Global Opioids Drug Revenue and Market Share by Regions (2016-2021) Chapter 3 Production Market Analysis 3.1 Global Production Market Analysis 3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis 3.1.2 2016-2021 Major Manufacturers Performance and Market Share 3.2 Regional Production Market Analysis 3.2.1 2016-2021 Regional Market Performance and Market Share 3.2.2 North America Market 3.2.3 East Asia Market 3.2.4 Europe Market 3.2.5 South Asia Market 3.2.6 Southeast Asia Market 3.2.7 Middle East Market 3.2.8 Africa Market 3.2.9 Oceania Market 3.2.10 South America Market 3.2.11 Rest of the World Market Chapter 4 Global Opioids Drug Sales, Consumption, Export, Import by Regions (2016-2021) 4.1 Global Opioids Drug Consumption by Regions (2016-2021) 4.2 North America Opioids Drug Sales, Consumption, Export, Import (2016-2021) 4.3 East Asia Opioids Drug Sales, Consumption, Export, Import (2016-2021) 4.4 Europe Opioids Drug Sales, Consumption, Export, Import (2016-2021) 4.5 South Asia Opioids Drug Sales, Consumption, Export, Import (2016-2021) 4.6 Southeast Asia Opioids Drug Sales, Consumption, Export, Import (2016-2021) 4.7 Middle East Opioids Drug Sales, Consumption, Export, Import (2016-2021) 4.8 Africa Opioids Drug Sales, Consumption, Export, Import (2016-2021) 4.9 Oceania Opioids Drug Sales, Consumption, Export, Import (2016-2021) 4.10 South America Opioids Drug Sales, Consumption, Export, Import (2016-2021) Chapter 5 North America Opioids Drug Market Analysis 5.1 North America Opioids Drug Consumption and Value Analysis 5.1.1 North America Opioids Drug Market Under COVID-19 5.2 North America Opioids Drug Consumption Volume by Types 5.3 North America Opioids Drug Consumption Structure by Application 5.4 North America Opioids Drug Consumption by Top Countries 5.4.1 United States Opioids Drug Consumption Volume from 2016 to 2021 5.4.2 Canada Opioids Drug Consumption Volume from 2016 to 2021 5.4.3 Mexico Opioids Drug Consumption Volume from 2016 to 2021 Chapter 6 East Asia Opioids Drug Market Analysis 6.1 East Asia Opioids Drug Consumption and Value Analysis 6.1.1 East Asia Opioids Drug Market Under COVID-19 6.2 East Asia Opioids Drug Consumption Volume by Types 6.3 East Asia Opioids Drug Consumption Structure by Application 6.4 East Asia Opioids Drug Consumption by Top Countries 6.4.1 China Opioids Drug Consumption Volume from 2016 to 2021 6.4.2 Japan Opioids Drug Consumption Volume from 2016 to 2021 6.4.3 South Korea Opioids Drug Consumption Volume from 2016 to 2021 Chapter 7 Europe Opioids Drug Market Analysis 7.1 Europe Opioids Drug Consumption and Value Analysis 7.1.1 Europe Opioids Drug Market Under COVID-19 7.2 Europe Opioids Drug Consumption Volume by Types 7.3 Europe Opioids Drug Consumption Structure by Application 7.4 Europe Opioids Drug Consumption by Top Countries 7.4.1 Germany Opioids Drug Consumption Volume from 2016 to 2021 7.4.2 UK Opioids Drug Consumption Volume from 2016 to 2021 7.4.3 France Opioids Drug Consumption Volume from 2016 to 2021 7.4.4 Italy Opioids Drug Consumption Volume from 2016 to 2021 7.4.5 Russia Opioids Drug Consumption Volume from 2016 to 2021 7.4.6 Spain Opioids Drug Consumption Volume from 2016 to 2021 7.4.7 Netherlands Opioids Drug Consumption Volume from 2016 to 2021 7.4.8 Switzerland Opioids Drug Consumption Volume from 2016 to 2021 7.4.9 Poland Opioids Drug Consumption Volume from 2016 to 2021 Chapter 8 South Asia Opioids Drug Market Analysis 8.1 South Asia Opioids Drug Consumption and Value Analysis 8.1.1 South Asia Opioids Drug Market Under COVID-19 8.2 South Asia Opioids Drug Consumption Volume by Types 8.3 South Asia Opioids Drug Consumption Structure by Application 8.4 South Asia Opioids Drug Consumption by Top Countries 8.4.1 India Opioids Drug Consumption Volume from 2016 to 2021 8.4.2 Pakistan Opioids Drug Consumption Volume from 2016 to 2021 8.4.3 Bangladesh Opioids Drug Consumption Volume from 2016 to 2021 Chapter 9 Southeast Asia Opioids Drug Market Analysis 9.1 Southeast Asia Opioids Drug Consumption and Value Analysis 9.1.1 Southeast Asia Opioids Drug Market Under COVID-19 9.2 Southeast Asia Opioids Drug Consumption Volume by Types 9.3 Southeast Asia Opioids Drug Consumption Structure by Application 9.4 Southeast Asia Opioids Drug Consumption by Top Countries 9.4.1 Indonesia Opioids Drug Consumption Volume from 2016 to 2021 9.4.2 Thailand Opioids Drug Consumption Volume from 2016 to 2021 9.4.3 Singapore Opioids Drug Consumption Volume from 2016 to 2021 9.4.4 Malaysia Opioids Drug Consumption Volume from 2016 to 2021 9.4.5 Philippines Opioids Drug Consumption Volume from 2016 to 2021 9.4.6 Vietnam Opioids Drug Consumption Volume from 2016 to 2021 9.4.7 Myanmar Opioids Drug Consumption Volume from 2016 to 2021 Chapter 10 Middle East Opioids Drug Market Analysis 10.1 Middle East Opioids Drug Consumption and Value Analysis 10.1.1 Middle East Opioids Drug Market Under COVID-19 10.2 Middle East Opioids Drug Consumption Volume by Types 10.3 Middle East Opioids Drug Consumption Structure by Application 10.4 Middle East Opioids Drug Consumption by Top Countries 10.4.1 Turkey Opioids Drug Consumption Volume from 2016 to 2021 10.4.2 Saudi Arabia Opioids Drug Consumption Volume from 2016 to 2021 10.4.3 Iran Opioids Drug Consumption Volume from 2016 to 2021 10.4.4 United Arab Emirates Opioids Drug Consumption Volume from 2016 to 2021 10.4.5 Israel Opioids Drug Consumption Volume from 2016 to 2021 10.4.6 Iraq Opioids Drug Consumption Volume from 2016 to 2021 10.4.7 Qatar Opioids Drug Consumption Volume from 2016 to 2021 10.4.8 Kuwait Opioids Drug Consumption Volume from 2016 to 2021 10.4.9 Oman Opioids Drug Consumption Volume from 2016 to 2021 Chapter 11 Africa Opioids Drug Market Analysis 11.1 Africa Opioids Drug Consumption and Value Analysis 11.1.1 Africa Opioids Drug Market Under COVID-19 11.2 Africa Opioids Drug Consumption Volume by Types 11.3 Africa Opioids Drug Consumption Structure by Application 11.4 Africa Opioids Drug Consumption by Top Countries 11.4.1 Nigeria Opioids Drug Consumption Volume from 2016 to 2021 11.4.2 South Africa Opioids Drug Consumption Volume from 2016 to 2021 11.4.3 Egypt Opioids Drug Consumption Volume from 2016 to 2021 11.4.4 Algeria Opioids Drug Consumption Volume from 2016 to 2021 11.4.5 Morocco Opioids Drug Consumption Volume from 2016 to 2021 Chapter 12 Oceania Opioids Drug Market Analysis 12.1 Oceania Opioids Drug Consumption and Value Analysis 12.2 Oceania Opioids Drug Consumption Volume by Types 12.3 Oceania Opioids Drug Consumption Structure by Application 12.4 Oceania Opioids Drug Consumption by Top Countries 12.4.1 Australia Opioids Drug Consumption Volume from 2016 to 2021 12.4.2 New Zealand Opioids Drug Consumption Volume from 2016 to 2021 Chapter 13 South America Opioids Drug Market Analysis 13.1 South America Opioids Drug Consumption and Value Analysis 13.1.1 South America Opioids Drug Market Under COVID-19 13.2 South America Opioids Drug Consumption Volume by Types 13.3 South America Opioids Drug Consumption Structure by Application 13.4 South America Opioids Drug Consumption Volume by Major Countries 13.4.1 Brazil Opioids Drug Consumption Volume from 2016 to 2021 13.4.2 Argentina Opioids Drug Consumption Volume from 2016 to 2021 13.4.3 Columbia Opioids Drug Consumption Volume from 2016 to 2021 13.4.4 Chile Opioids Drug Consumption Volume from 2016 to 2021 13.4.5 Venezuela Opioids Drug Consumption Volume from 2016 to 2021 13.4.6 Peru Opioids Drug Consumption Volume from 2016 to 2021 13.4.7 Puerto Rico Opioids Drug Consumption Volume from 2016 to 2021 13.4.8 Ecuador Opioids Drug Consumption Volume from 2016 to 2021 Chapter 14 Company Profiles and Key Figures in Opioids Drug Business 14.1 Teva 14.1.1 Teva Company Profile 14.1.2 Teva Opioids Drug Product Specification 14.1.3 Teva Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.2 Purdue Pharma 14.2.1 Purdue Pharma Company Profile 14.2.2 Purdue Pharma Opioids Drug Product Specification 14.2.3 Purdue Pharma Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.3 Mallinckrodt 14.3.1 Mallinckrodt Company Profile 14.3.2 Mallinckrodt Opioids Drug Product Specification 14.3.3 Mallinckrodt Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.4 Amneal Pharma 14.4.1 Amneal Pharma Company Profile 14.4.2 Amneal Pharma Opioids Drug Product Specification 14.4.3 Amneal Pharma Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.5 Collegium 14.5.1 Collegium Company Profile 14.5.2 Collegium Opioids Drug Product Specification 14.5.3 Collegium Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.6 J&J 14.6.1 J&J Company Profile 14.6.2 J&J Opioids Drug Product Specification 14.6.3 J&J Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.7 Endo 14.7.1 Endo Company Profile 14.7.2 Endo Opioids Drug Product Specification 14.7.3 Endo Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.8 Pfizer 14.8.1 Pfizer Company Profile 14.8.2 Pfizer Opioids Drug Product Specification 14.8.3 Pfizer Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.9 INSYS 14.9.1 INSYS Company Profile 14.9.2 INSYS Opioids Drug Product Specification 14.9.3 INSYS Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.10 Mylan 14.10.1 Mylan Company Profile 14.10.2 Mylan Opioids Drug Product Specification 14.10.3 Mylan Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.11 Hikma 14.11.1 Hikma Company Profile 14.11.2 Hikma Opioids Drug Product Specification 14.11.3 Hikma Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.12 Egalet 14.12.1 Egalet Company Profile 14.12.2 Egalet Opioids Drug Product Specification 14.12.3 Egalet Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) Chapter 15 Global Opioids Drug Market Forecast (2022-2027) 15.1 Global Opioids Drug Consumption Volume, Revenue and Price Forecast (2022-2027) 15.1.1 Global Opioids Drug Consumption Volume and Growth Rate Forecast (2022-2027) 15.1.2 Global Opioids Drug Value and Growth Rate Forecast (2022-2027) 15.2 Global Opioids Drug Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027) 15.2.1 Global Opioids Drug Consumption Volume and Growth Rate Forecast by Regions (2022-2027) 15.2.2 Global Opioids Drug Value and Growth Rate Forecast by Regions (2022-2027) 15.2.3 North America Opioids Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.4 East Asia Opioids Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.5 Europe Opioids Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.6 South Asia Opioids Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.7 Southeast Asia Opioids Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.8 Middle East Opioids Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.9 Africa Opioids Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.10 Oceania Opioids Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.11 South America Opioids Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.3 Global Opioids Drug Consumption Volume, Revenue and Price Forecast by Type (2022-2027) 15.3.1 Global Opioids Drug Consumption Forecast by Type (2022-2027) 15.3.2 Global Opioids Drug Revenue Forecast by Type (2022-2027) 15.3.3 Global Opioids Drug Price Forecast by Type (2022-2027) 15.4 Global Opioids Drug Consumption Volume Forecast by Application (2022-2027) 15.5 Opioids Drug Market Forecast Under COVID-19 Chapter 16 Conclusions Research Methodology
Related reports
Non-Hodgkin Lymphoma Therapeutics Market
$2000-$6000
Acrylic Teeth Market
$3600-$7000